https://doi.org/10.1172/JCI195784 Sylvie Alonso & team develop a nasal vaccine booster that induces robust and sustained, cross-clade systemic and mucosal protective immunity in COVID19 mRNA vaccinated populations.
1Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine and.
2Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore.
3Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia.